Jelle Tichelaar
Overview
Explore the profile of Jelle Tichelaar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
441
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hartjes M, Elsevier A, Grijpma J, Richir M, van Agtmael M, Tichelaar J
Br J Clin Pharmacol
. 2025 Feb;
PMID: 39993935
Introduction: Therapeutic decision-making often involves weighing several treatment options on the basis of, among other things, the disease profile, patient characteristics but also prescriber-specific factors. This study investigated the factors...
2.
Mahomedradja R, Wang S, Catherina Eve Sigaloff K, Tichelaar J, Adriaan van Agtmael M
Expert Opin Drug Saf
. 2025 Feb;
:1-18.
PMID: 39973626
Introduction: Prescribing errors (PEs) in hospital care lead to patient harm, prolonged hospital stays, readmissions, and mortality. Despite interventions that successfully target 'high risk' populations in trials, PE rates remain...
3.
Donker E, van Rosse F, Janssen B, Knol W, Dumont G, van Smeden J, et al.
Eur J Pharmacol
. 2025 Jan;
989():177266.
PMID: 39798917
Introduction: The Dutch National Pharmacotherapy Assessment (DNPA) was introduced in 2013 to improve clinical pharmacology and therapeutics (CPT) education. This study investigated final-year medical students' perceived motivation and level of...
4.
Donker E, van Rosse F, Janssen B, Knol W, Dumont G, van Smeden J, et al.
Eur J Pharmacol
. 2025 Jan;
989():177267.
PMID: 39798914
Background: The Dutch National Pharmacotherapy Assessment (DNPA), which focuses on assessing medication safety and essential drug knowledge, was introduced to improve clinical pharmacology and therapeutics education in the Netherlands. This...
5.
Hartjes M, Richir M, Cazaubon Y, Donker E, van Leeuwen E, Likic R, et al.
BMC Med Educ
. 2024 Nov;
24(1):1360.
PMID: 39587582
Background: Despite efforts to improve undergraduate clinical pharmacology & therapeutics (CPT) education, prescribing errors are still made regularly. To improve CPT education and daily prescribing, it is crucial to understand...
6.
Mahomedradja R, Lissenberg-Witte B, Sigaloff K, Tichelaar J, van Agtmael M
Br J Clin Pharmacol
. 2024 Oct;
91(3):789-798.
PMID: 39419636
Background: Evaluating a patient's medication list is critical to reduce prescribing errors (PEs), but is a labour- and time-intensive process. Identification of patients at risk of PEs could improve the...
7.
Piet J, Booth A, Donker E, De Ponti F, Lunghi C, Poluzzi E, et al.
Lancet Planet Health
. 2024 Sep;
8(10):e715-e716.
PMID: 39303730
No abstract available.
8.
Donker E, Bakkum M, Richir M, Tichelaar J
Br J Clin Pharmacol
. 2024 Mar;
PMID: 38486438
No abstract available.
9.
Brinkman D, Wackwitz N, Donker E, Tichelaar J
Br J Clin Pharmacol
. 2024 Mar;
90(5):1357-1364.
PMID: 38439145
To prepare medical students appropriately for the management of toxicological emergencies, we have developed a simulation-based medical education (SBME) training in acute clinical toxicology. Our aim is to report on...
10.
Mahomedradja R, Tichelaar J, Mokkink L, Sigaloff K, van Agtmael M
Br J Clin Pharmacol
. 2024 Feb;
90(5):1280-1300.
PMID: 38369619
Aims: In-hospital prescribing errors may result in patient harm, such as prolonged hospitalisation and hospital (re)admission, and may be an emotional burden for the prescribers and healthcare professionals involved. Despite...